Share

February 25, 2020; 94 (8) Editorial

Traumatic brain injury and α-synuclein

Proceed with caution

Ethan G. Brown, Samuel M. Goldman
First published January 28, 2020, DOI: https://doi.org/10.1212/WNL.0000000000008991
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
176

Share

Article Information

vol. 94 no. 8 335-336
DOI: 
https://doi.org/10.1212/WNL.0000000000008991
PubMed: 
31992678
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 28, 2020.

Article Versions

Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Ethan G. Brown, MD and
    2. Samuel M. Goldman, MD, MPH
  1. Ethan G. Brown, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Travel award for the Parkinson Study Group Annual Meeting (U13 Grant)

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Has received consulting fees from: 1) NEJM Knowledge+ 2) Oscar Health 3) Rune Labs Inc.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Biogen Inc 2) Gateway Institute for Brain Research Inc

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. 1) Michael J. Fox Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Samuel M. Goldman, MD, MPH
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Biogen

    Research Support, Government Entities:

    1. (1) NIOSH, R21OH010372, PI, 2017 (2) ATSDR, U61TS000238-R9-03, PI, 2017-2019 (3) Health Resources and Services Administration (HRSA), D33HP31668, Investigator, 2018-2019 (4) National Institute on Aging, P0524430, 2018-2019

    Research Support, Academic Entities:

    1. San Francisco Veterans Affairs Health Care System

    Research Support, Foundations and Societies:

    1. (1) Michael J Fox Foundation (2) Gateway Institute for Brain Research

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the University of California, San Francisco.
  1. Correspondence
    Dr. Goldman samuel.goldman{at}ucsf.edu

Article usage

Article usage: January 2020 to October 2023

AbstractFullPdfSource
Jan 20207907Highwire
Feb 20203725740Highwire
Mar 20201291416Highwire
Apr 202070411Highwire
May 20203912Highwire
Jun 20202933Highwire
Jul 20204912Highwire
Aug 20202310Highwire
Sep 20201411Highwire
Oct 20206023Highwire
Nov 20204135Highwire
Dec 20203200Highwire
Jan 20214985Highwire
Feb 20213715Highwire
Mar 20212614Highwire
Apr 20216125Highwire
May 20213918Highwire
Jun 20214335Highwire
Jul 20212300Highwire
Aug 20211702Highwire
Sep 20212801Highwire
Oct 20213300Highwire
Nov 20212307Highwire
Dec 20212702Highwire
Jan 20221402Highwire
Feb 20224031Highwire
Mar 20221523Highwire
Apr 20223512Highwire
May 20222200Highwire
Jun 20223301Highwire
Jul 20222403Highwire
Aug 20221614Highwire
Sep 20222023Highwire
Oct 20224023Highwire
Nov 20222104Highwire
Dec 20221121Highwire
Jan 20232701Highwire
Feb 20231701Highwire
Mar 20232543Highwire
Apr 20231811Highwire
May 20231410Highwire
Jun 20231504Highwire
Jul 20232512Highwire
Aug 20232700Highwire
Sep 2023922Highwire
Oct 20231931Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles